Literature DB >> 16351214

Polymeric nanoparticle preparation that eradicates tumors.

Jason R McCarthy1, J Manuel Perez, Christian Brückner, Ralph Weissleder.   

Abstract

We report the production of poly(lactic-co-glycolic acid) nanoparticles that encapsulate the photosensitizer meso-tetraphenylporpholactol. These nanoparticles are stable and nonphototoxic upon systemic administration. Upon cellular internalization, the photosensitizer is released from the nanoparticle and becomes highly phototoxic. Irradiation with visible light results in cell-specific killing of several cancer cell lines. Importantly, in vivo experiments show complete eradication of cancers in mouse models. The concept of photosensitizers with selective phototoxicity should have widespread applications in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16351214     DOI: 10.1021/nl0519229

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  49 in total

1.  Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

Review 2.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.

Authors:  Ki Young Choi; Gang Liu; Seulki Lee; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2011-12-01       Impact factor: 7.790

Review 3.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

4.  meso-arylporpholactones and their reduction products.

Authors:  Christian Brückner; Junichi Ogikubo; Jason R McCarthy; Joshua Akhigbe; Michael A Hyland; Pedro Daddario; Jill L Worlinsky; Matthias Zeller; James T Engle; Christopher J Ziegler; Matthew J Ranaghan; Megan N Sandberg; Robert R Birge
Journal:  J Org Chem       Date:  2012-07-19       Impact factor: 4.354

5.  A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis.

Authors:  Jason R McCarthy; Ethan Korngold; Ralph Weissleder; Farouc A Jaffer
Journal:  Small       Date:  2010-09-20       Impact factor: 13.281

Review 6.  Gastrointestinal cancers in the era of theranostics: Updates and future perspectives.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Samer Tabchi
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 7.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

8.  meso-Tetra(pentafluorophenyl)porphyrin as an efficient platform for combinatorial synthesis and the selection of new photodynamic therapeutics using a cancer cell line.

Authors:  Diana Samaroo; Mikki Vinodu; Xin Chen; Charles Michael Drain
Journal:  J Comb Chem       Date:  2007-09-15

9.  Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.

Authors:  Minfang Zhang; Tatsuya Murakami; Kumiko Ajima; Kunihiro Tsuchida; Atula S D Sandanayaka; Osamu Ito; Sumio Iijima; Masako Yudasaka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

10.  Aliphatic hyperbranched polyester: a new building block in the construction of multifunctional nanoparticles and nanocomposites.

Authors:  Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  Langmuir       Date:  2010-04-20       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.